+ Watch PACB
on My Watchlist
things are improving under new management
Technology is rule breaking and management is focused on improving throughput. Sales have been going up and industry seems to be providing some free promotion with all the papers that are being written/published.
The company is selling short term investments and stock in order to keep cash at a minimal level. Unless something actually sells, the company will either need to go to the well again or go insolvent.
Among other things, 5 year high for corporate revenues much more recent than corresponding low.
New product, product updates, growth ahead
This stock has been much higher than this and will return to 2 bagger status
Has it finally turned the corner? It's been up pretty big lately, and I'm making a CAPS bet that it'll continue.
Both PACB and GNOM are beat up right now, and it's only a matter of time before one of them takes off. It may be smart to buy both instead of guessing which one
This is the risky one, but they will either pull the rabbit out of the hat or not. They have a machine that does gene resequencing for about a thousand dollars. A stock at the price I would be willing to invest in because I believe in the product and will put some money behind it. Just not a lot of money. All I can lose is 3.93 a share.
No place to go but up.
investigation...and i own some. i am the kiss of death!
The floor where I work just received one of their next-gen sequencers. It is quite possibly the coolest thing I have ever seen. I think it is fair to say that adoption will be slower than management's original optimistic projections because of the price tag; however, my suspicion is that the razor-and-blade model will allow them to eventually become profitable as specialized centers like ours adopt them. They really do have capabilities that leave the competition in the dust for certain applications.
This highly volitile stock is definately a speculative play for a while. Shares droped 30% after some bad news regarding gross margins. I believe that drop was a bit drastic.
Don't you want a genetic analysis too?
They had a great quarterly report but got creamed due to a JPM downgrade. It's a long-term spec stock with great potential.
Mark this date down. Who buys 1.5 million shares after hours? Something is going on.............
Is gearing up for explosive growth.
i like where their technology is going
Clearly the most powerful technology with a large void to fill in the sequencing space. Granted it will have a slow start as centers have to phase out current technology over time but once momentum picks up this run will be hard to stop.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions